Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005251

General Counsel sold 67,927 shares at an average $6.83 ($463,935)

  • General Counsel acquired 67,927 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
MOORE JOHN R General Counsel 2022-06-16 Option exercise +14,722 $1.93 $28,413 17,722 D
MOORE JOHN R General Counsel 2022-06-16 Sale −14,722 $6.17 $90,805 3,000 D
MOORE JOHN R General Counsel 2022-06-17 Option exercise +22,127 $1.93 $42,705 25,127 D
MOORE JOHN R General Counsel 2022-06-17 Sale −22,127 $6.62 $146,434 3,000 D
MOORE JOHN R General Counsel 2022-06-21 Option exercise +13,508 $0.71 $9,591 16,508 D
MOORE JOHN R General Counsel 2022-06-21 Option exercise +17,570 $1.93 $33,910 34,078 D
MOORE JOHN R General Counsel 2022-06-21 Sale −31,078 $7.29 $226,695 3,000 D
Derivatives
MOORE JOHN R General Counsel 2022-06-16 Option exercise · Stock Option (Right to Buy) −14,722 181,614 D
MOORE JOHN R General Counsel 2022-06-17 Option exercise · Stock Option (Right to Buy) −22,127 159,487 D
MOORE JOHN R General Counsel 2022-06-21 Option exercise · Stock Option (Right to Buy) −17,570 141,917 D
MOORE JOHN R General Counsel 2022-06-21 Option exercise · Stock Option (Right to Buy) −13,508 121,562 D
Open-market sales · 67,927 sh · avg $6.83 · $463,935
Loading xslF345X03/primarydocument.xml…